Compare AU
Compare EX20 vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Australian Ex-20 Portfolio Diversifier ETF (EX20) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
EX20 | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 22 | 7 |
Median incremental investment | $1,993.50 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,584.46 | $192.66 |
Average age group | > 35 | > 35 |
Key Summary
EX20 | EDOC | |
|---|---|---|
Strategy | EX20.AX was created on 2016-10-05 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. EX20.AX aims to track the performance of an index (before fees and expenses) comprising the 180 largest stocks listed on the ASX, after excluding the 20 largest, based on their market capitalisation. | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | SUNCORP GROUP LTD (2.54 %) COCHLEAR LTD (2.45 %) BRAMBLES LTD (2.39 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Materials (16.44 %) Financials (13.89 %) Industrials (13.22 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | Australia (89.38 %) United States (5.50 %) New Zealand (3.83 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.25 % | 0.67 % |
Key Summary
EX20 | EDOC | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Australia Completion Cap Index - AUD | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.25 % | 0.67 % |
Price | $21.79 | $10.14 |
Size | $370.934 million | $1.618 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 3.56 % | - % |
Market | ASX | ASX |
First listed date | 07/10/2016 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
EX20 | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 22 | 7 |
Median incremental investment | $1,993.50 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,584.46 | $192.66 |
Average age group | > 35 | > 35 |
Pros and Cons
EX20 | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
EX20 | EDOC |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |